AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects

NCT00995605 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Reached sufficient pharmacokinetic exposures

Conditions

Healthy Volunteers

Interventions

DRUG: AMAP102

Sponsor

AnaMar AB